文献速递类风湿关节炎

脂质体包裹的antagomiR-155-5p恢复抗炎巨噬细胞并改善类风湿关节炎临床前模型中的关节炎

Liposomal AntagomiR-155-5p Restores Anti-Inflammatory Macrophages and Improves Arthritis in Preclinical Models of Rheumatoid Arthritis.
PubMed 文献 · Arthritis Rheumatol · 2023-11-21

在胶原诱导性关节炎和K/BxN血清转移性关节炎两种小鼠模型中,静脉注射包裹antagomiR-155-5p的PEG化脂质体可减少关节炎评分和爪肿胀,并恢复骨髓单核细胞向抗炎M2样巨噬细胞分化的能力,而脾脏B细胞和T细胞功能无显著变化。

要点

  • 包裹antagomiR-155-5p的PEG脂质体较对照脂质体或游离antagomiR-155-5p降低关节炎评分和爪肿胀。
  • 该治疗恢复骨髓单核细胞向抗炎巨噬细胞分化的缺陷,脾脏B细胞和T细胞无显著功能变化。
  • 荧光标记脂质体注射后1小时分布于炎症关节,48小时后肝脏蓄积提示肝清除。

核心结论

  • 静脉注射包裹于PEG脂质体的antagomiR-155-5p可将小RNA递送至单核细胞和巨噬细胞,并减少小鼠类风湿关节炎模型的关节炎症,作者认为这是人类疾病中有前景的策略。

研究设计与样本

  • 研究采用胶原诱导性关节炎和K/BxN血清转移性关节炎两种类风湿关节炎临床前小鼠模型。
  • antagomiR-155-5p或antagomiR对照被包裹于大小100 nm、zeta电位-10 mV、包封效率高于80%的PEG脂质体中。
  • 关节炎诱导后,小鼠静脉注射1.5 nmol/100 μL含antagomiR-155-5p或对照的PEG脂质体。

主要发现

  • 荧光标记PEG脂质体注射后1小时在炎症关节显示分布,48小时后肝脏蓄积提示肝清除。
  • 注射含antagomiR-155-5p的PEG脂质体较含antagomiR对照的PEG脂质体或系统递送游离antagomiR-155-5p降低关节炎评分和爪肿胀。
  • 含antagomiR-155-5p的PEG脂质体治疗恢复骨髓单核细胞向抗炎巨噬细胞分化的缺陷,其他免疫细胞包括脾脏B细胞和T细胞无显著功能变化。

临床怎么用

  • 原文未据此给出临床推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: We previously reported an increased expression of microRNA-155 (miR-155) in the blood monocytes of patients with rheumatoid arthritis (RA) that could be responsible for impaired monocyte polarization to anti-inflammatory M2-like macrophages. In this study, we employed two preclinical models of RA, collagen-induced arthritis and K/BxN serum transfer arthritis, to examine the therapeutic potential of antagomiR-155-5p entrapped within PEGylated (polyethylene glycol [PEG]) liposomes in resolution of arthritis and repolarization of monocytes towards the anti-inflammatory M2 phenotype. METHODS: AntagomiR-155-5p or antagomiR-control were encapsulated in PEG liposomes of 100 nm in size and -10 mV in zeta potential with high antagomiR loading efficiency (above 80%). Mice were injected intravenously with 1.5 nmol/100 μL PEG liposomes containing antagomiR-155-5p or control after the induction of arthritis. RESULTS: We demonstrated the biodistribution of fluorescently tagged PEG liposomes to inflamed joints one hour after the injection of fluorescently tagged PEG liposomes, as well as the liver's subsequent accumulation after 48 hours, indicative of hepatic clearance, in mice with arthritis. The injection of PEG liposomes containing antagomiR-155-5p decreased arthritis score and paw swelling compared with PEG liposomes containing antagomiR-control or the systemic delivery of free antagomiR-155-5p. Moreover, treatment with PEG liposomes containing antagomiR-155-5p led to the restoration of bone marrow monocyte defects in anti-inflammatory macrophage differentiation without any significant functional change in other immune cells, including splenic B and T cells. CONCLUSION: The injection of antagomiR-155-5p encapsulated in PEG liposomes allows the delivery of small RNA to monocytes and macrophages and reduces joint inflammation in murine models of RA, providing a promising strategy in human disease.

来源:Arthritis Rheumatol,查看原文。版权归原作者所有。

引用

  1. Paoletti A, Ly B, Cailleau C, et al. Liposomal AntagomiR-155-5p Restores Anti-Inflammatory Macrophages and Improves Arthritis in Preclinical Models of Rheumatoid Arthritis. Arthritis Rheumatol. 2023. PMID: 37527031. doi:10.1002/art.42665

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。